Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $KBEV.C) (OTC: $KBEVF) (CSE: $FONE.C) (OTCQB: $FLOOF) (CSE: $MTEC.C) and (TSXV: $GENE.V) (OTCQX: $IVITF)
Delta, Kelowna, BC - January 17, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Koios Beverage Corp. announced that it has received its first purchase order with GNC Holdings, Inc. (GNC), a leading global health and wellness brand with thousands of retail stores across the US and Canada.
It is the largest single order for product that Koios has received in its corporate history.
The order is for Koios's four most popular flavours - Apricot Vanilla, Berry Genius, Peach Mango, and Pear Guava. The beverages will be available for purchase initially in approximately 2,700 GNC retail stores in the US.
Pittsburgh-based GNC has more than 6,400 retail locations throughout the United States and Canada and franchise operations in approximately 50 international markets. GNC Canada is based in Mississauga, Ontario and operates as a subsidiary of GNC.
"The response to our new product lines at a regional level has exceeded our forecasts and expectations," said Koios CEO Chris Miller. "Demand across the US has grown exponentially and our new national roll out with GNC will allow us to serve our ever-growing consumer base."
Flower One Holdings Inc. today announced a new licensing agreement and Brand Partnership for cannabis-product fulfillment in Nevada. Flower One is licensed to manufacture, distribute and sell the two signature cannabis products from Flyte Concentrates (Flyte™) to all 130 cannabis retailers in Nevada, marking the consumer brand's U.S. market entry following successful launches in other markets.
"This is another milestone partnership for Flower One," said Ken Villazor, Flower One's President and CEO. "Adding Flyte to Flower One's portfolio of Brand Partners further diversifies the line of products we have to offer our retail partners. Flower One is excited to expedite the market entry of Flyte's distillate and edible product lines in Nevada, which hosts more than 55 million tourists annually from all over the world, and is one of the most lucrative cannabis markets in the United States."
As a distillate brand, Flyte is best known for its two product lines: FlytePen and JetPack. FlytePen is a slim distillate vaporizer system with a cartridge containing 0.8ml of premium cannabis oil. Using a proprietary process and formulation, the FlytePen can rapidly vaporize the thickest and most purified cannabis oils. Flyte JetPacks are convenient single-dose 10ml liquid THC or CBD shots, about 2mm thick and about the size of a credit card. The contents of the package can be added to any hot or cold beverage for a discreet experience.
Cannvas MedTech Inc., a leading digital cannabis educator and business technology company, and Advica Health, an innovative healthcare navigation service allowing members to access an independent appraisal of their health needs and circumstances, announced the signing of a definitive contract whereby Cannvas.Me will be the exclusive provider of cannabis education and information to the Advica Health community.
"Advica Health is at the forefront of delivering medical treatment efficiently on a membership basis and we are very pleased to become their exclusive provider of physician-backed cannabis education," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. "The need to educate Canadians about cannabis and its potential health benefits has never been greater and Cannvas.Me is an ideal learning tool for patients looking to take better control of their own health and wellness through organizations like Advica Health who have their patient's best interests at heart. We believe that with a dedicated cannabis education section on the Advica portal where patients and health care professionals will be able to access evidence-based education and information about cannabis, Advica members will be better positioned to make informed decisions about their health treatments."
Advica Health offers members access to the best facilities at home or abroad and assists in obtaining advice, treatment options and solutions to current health care situations in the most efficient manner possible. Each case is approached on an individual and personalized basis to help navigate the healthcare system and collaboratively create an effective health plan with ongoing care management and support from nurse navigators. Advica is constantly bringing innovative healthcare solutions to its membership with a strong focus on preventative health and wellness, and helps members focus on healthy living to positively impact their overall productivity and quality of life.
INVICTUS MD STRATEGIES CORP. announced that it has submitted its application to list its common shares on the NASDAQ Capital Market. In advance of listing on NASDAQ, the Company will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission. The listing of the Company's Shares on NASDAQ remains subject to the approval of NASDAQ and the satisfaction of all applicable listing and regulatory requirements, including the effectiveness of the Form 40-F Registration Statement.
Subject to approval for listing, it is anticipated that the Company's Shares, including the existing Shares trading on the OTCQX under the ticker symbol "IVITF", will trade on NASDAQ under the ticker symbol "INV". The Company's Shares will continue to trade on the TSXV under the ticker symbol "GENE" and on the Frankfurt Stock Exchange under the ticker symbol "8IS1". A trading date will be made public once all regulatory formalities are satisfied.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
#Cannabisstocks: ISBG (OTCQB: $ISBG) Books First Major #CBD Purchase Order, Sees Accelerating 2019 Financial Performance, @DrinkISBG
LAS VEGAS, NV - January 17, 2019 (Investorideas.com Newswire) International Spirits and Beverage Group Inc. (OTCQB:ISBG) ("ISBG" or the "Company"), a top-tier brand incubator in the Global Wine & Spirits and CBD-Infused Products markets, is thrilled to announce its first purchase order for the Company’s new P19 CBD Gummies. The order exceeds $115K. In addition, the Company now anticipates revenues from its recently launched Health and Wellness segment to top $300K during Q1 2019 based on orders for CBD Gummies and other new product releases.
That would represent potential annualized y/y growth on the top line for this segment of 233% following full-year 2018 billed sales of $360K in comparable items and services.
Management anticipates strong top line growth across operational segments in 2019 due to the timing of its strong CBD products launch and its new Health and Wellness segment, coming just on the heels of the historic signing of the 2018 Farm Bill, as well as the Company’s overhaul of its Besado Tequila brand.
ISBG CEO Terry Williams stated, "The removal of hemp from federal prohibition under the Controlled Substances Act of 1970 will, according to all analysis we have received, indeed mean a broad expansion in the scale and scope of the total U.S. hemp industry. And experts expect this to have a dramatic and disproportionately positive impact on growth in the hemp-derived CBD products market segment. We expect this to be a major performance driver for ISBG Health and Wellness in 2019."
The Company also anticipates sharply improved overall efficiency given the development of its Internet of Things ("IoT") supply chain management technology. The Company has begun to integrate IoT tagging for supply chain management, allowing for GPS tracking, geospatial coordination, temperature monitoring and additional features, including enabling features such as NFC and RFID chips to register information and eliminate unnecessary input and output record management tasks.
"With our expansion into the CBD products space, we now have enough logistical complexity to materially streamline costs through the implementation of our IoT supply chain technology," continued Mr. Williams. "Everything is suddenly coming together right now for this Company - the Farm Bill, strong early growth in our new Health and Wellness division, our Besado overhaul, our integration of IoT. It’s an extremely exciting time for ISBG!"
About ISBG:
International Spirits and Beverage Group (ISBG) is an authorized importer, licensor, and marketer of premium beverage brands, with sales of innovative products and brands worldwide. Based in Nevada, the Company's expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISBG intends to nurture emerging brands through critical stages of market development, including conceptualization, go-to-market strategy, supply chain and logistics engineering, integrated marketing, and distribution. In addition, ISBG has now established itself as a health and wellness company with a focus on reshaping the CBD products market through state-of-the-art nanotechnology processes, developing a wide range of nano-infused CBD gummies and beverages formulations. These products will be sold through the Company’s website, as well as through established wholesale and retail distribution channels. The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.
Forward Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could", "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed from time to time with OTC Markets (www.otcmarkets.com).
For Additional Investor Information:
International Spirit & Beverage Group, Inc. info@isbg.global
Disclosure: Investorideas. does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: the publishing of this ISBG news release is a paid for service. Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
